Introduction {#Sec1}
============

Foot-and-mouth disease (FMD) is an economically devastating disease of intensive livestock farming and high production animals, caused by a virus member of the *Apthovirus* genus within the *Picornaviridae* family, and characterised by an acute and highly contagious vesicular disease which can develop into persistent infection. Vesicular lesions resulting from FMD infection are mainly found in tongue, lips and feet but in some cases lesions also can occur in snout, muzzle, teats, skin and rumen. The disease is characterised by a very short incubation period and high level of virus excretion, particularly in pigs \[[@CR1]\]. In wildlife, the FMD pathogenesis varies from a completely inapparent to a rare acutely lethal infection, making the diagnosis difficult either because the variability in the severity of presenting clinical signs is greater than in domestic livestock or because it tends to be subclinical for the particular species/virus combination \[[@CR2],[@CR3]\]. The transmission dynamic of FMD in sub-Saharan Africa is mainly driven by two epidemiological cycles: one in which wildlife plays a significant role in maintaining and spreading the disease to other susceptible wild and/or domestic ruminants \[[@CR4]-[@CR6]\], whilst with the second the virus is solely transmitted within domestic populations and hence is independent of wildlife. More than 70 wild animal species have been demonstrated to be susceptible to the FMD virus (FMDV) either by natural infection or by experimental challenge, and on several occasions the virus has been isolated from naturally infected animals \[[@CR7]\]. Among these, Cape buffalo (*Syncerus caffer caffer*) has been clearly shown to serve as long-term maintenance host (i.e. carrier) for the Southern African Territories (SAT) FMDV serotypes \[[@CR8]-[@CR10]\], and in populations of Cape buffalo the virus has been estimated to persist for 24 years or longer \[[@CR11]\]. Infection in buffalo is subclinical and normally occurs in calves as soon as maternal antibodies wane at 2--6 months of age. Acutely infected buffalo provide sources of infection for other ruminants, both domestic and wild, directly or through other species which have contracted the infection from buffalo \[[@CR5],[@CR6]\]. Although the implication of the buffalo carriers in the epidemiology of FMD has not been fully clarified, they have so far been shown to transmit the disease while in that state \[[@CR4],[@CR8],[@CR12]\]. Phylogenetic relationships between SAT types FMDV strains isolated from cattle and those carried by buffalo have been reconstructed from different area of southern Africa, proving that contacts between livestock and buffalo regularly result in FMD outbreaks among cattle \[[@CR13],[@CR14]\]. Furthermore, available evidence based on FMDV genome sequencing indicates that impala (*Aepyceros melampus*) populations of the Kruger National Park -- South Africa, usually become infected with SAT viruses derived from buffalo \[[@CR5]\]. On occasions SAT lineages were demonstrated to have been transmitted first from buffalo to impala and then from impala to cattle \[[@CR6],[@CR15]\]. Conceived as such, impala can provide a conduit of infection between buffalo and livestock, acting as an important intermediate between domestic and wild ruminants and as an amplifying host in the context of FMD transmission dynamics \[[@CR16]\]. Presence of antibodies against the FMDV in several wildlife species has been documented in studies conducted in different countries of the African continent, but mainly within its eastern and southern regions \[[@CR16]-[@CR18]\]. In addition, serological screenings implemented in East African countries have indicated potential infections of Cape buffalo with A and O FMDV serotypes \[[@CR19]-[@CR23]\], although current data do not support the primary role of buffalo and other wild animal species in the transmission of those FMDV serotypes generally occurring in domestic ruminants. This represents an important pattern of the FMD transmission dynamics in large parts of sub-Saharan Africa that still remains to be explained. Much is already known about the role that Cape buffalo plays in the FMD epidemiology, largely from studies conducted in South and East Africa; conversely, knowledge on the relationship between FMDV and wildlife and/or other buffalo subspecies that populate the rangelands of western and central African regions has been less thorough. In order to progress in the knowledge gap of the FMD epidemiology in sub-Saharan Africa and to further investigate the role of wildlife in the transmission of FMD, in this study the prevalence of antibodies against the FMDV nonstructural protein (NSP) and serological profiles of six out of the seven FMDV serotypes have been reconstructed from wildlife samples collected from national parks and faunal reserves of West and Central Africa. The aims of this study were: firstly, to produce an overall picture of the FMD prevalence in wildlife and mainly in buffalo subspecies of West and Central Africa, also characterising risk factors likely associated with the observed prevalence; secondly, to identify the FMDV serotypes potentially circulating in resident buffalo populations within the study area. In addition, potential limitations of diagnostic testing procedures used have been evaluated.

Materials and methods {#Sec2}
=====================

Study population {#Sec3}
----------------

The study was undertaken on serum samples collected from wild ruminants and pigs species during the African Wildlife Veterinary Project \[[@CR24]\], as part of the Pan-African Rinderpest Campaign (PARC) and the subsequent programme for the Pan-African Control of Epizootics (PACE) implemented in 34 countries across the African continent between 1986 and 2007. Wildlife species and sampling sites were selected at the time according to susceptibility to the Rinderpest (RP) virus, population biology (i.e. richness, gregarious behaviour, and seasonal movements), interface between livestock and wildlife, and their availability for veterinary interventions. Sampling was performed using purposive sampling by immobilisation, opportunistic sampling by cropping and/or hunting and during field investigations of reported episodes of disease and mortality. From the whole collection stored at the Centre de Coopération Internationale en Recherche Agronomique pour le Développement (CIRAD), Montpellier -- France, 696 sera collected between 1999 and 2003 were selected as representative of wildlife populations present in West and Central Africa (Table [1](#Tab1){ref-type="table"}; Figure [1](#Fig1){ref-type="fig"}). In addition, further 19 samples collected from cattle within the transfrontier area of the Central African Republic and Chad were included for comparative purpose. Extracted aliquots were sent to The Pirbright Institute, Pirbright -- United Kingdom (UK), for diagnostic testing.Table 1Wildlife samples tested allocated by region, country and species of collection.**RegionCountryNo. Buffalo SamplesNo. Other WildlifeTOTWest Africa**Benin181129Burkina Faso53035Nigeria178**TOT**244872**Central Africa**Cameroun-22Central African Republic81247328Chad53203256Democratic Republic of Congo34-34Gabon4-4**TOT**172452624**TOT**196500696^††^Not including the 19 samples collected from cattle.Figure 1**Geographical locations of the wildlife samples selected by species.** Distributional extents of buffalo subspecies of the *Syncerus* genus sourced and adapted from \[[@CR68]\].

Testing methodology {#Sec4}
-------------------

The sample collection was initially screened for antibodies against the highly conserved NSP of the FMDV using the PrioCHECK® FMDV NS Enzyme-Linked Immunosorbent Assay (ELISA) test kit (Prionics AG, Switzerland), according to the manufacturer protocol \[[@CR25]\]. Specifically, a positive result was considered with a Percentage of Inhibition (PI) value of ≥50, whereas a strong positive result was set at a PI value of ≥70. Subsequently, the NS ELISA positive reactive sera were further assessed using the Solid Phase Competition ELISA (SPCE) *in-house* test developed at The Pirbright Institute -- UK \[[@CR26],[@CR27]\], thus enabling the qualitative and quantitative characterisation of the specific antibody responses to 6 of the 7 FMDV serotypes (A, O, C, SAT 1, SAT 2 and SAT 3) and, therefore, the FMDV serotyping profile of each of the serotypes present in Africa at the time of the sampling. The cut-off for the SPCE was set at a PI value of ≥50 for serotypes A, O and C, whilst a value of ≥40 PI was set for SATs serotypes \[[@CR26]\]. Since the SPCE has not been validated for testing wildlife sera, the data were further reassessed increasing the cut-off to a value of ≥60 PI for serotypes A, O and C, and of ≥50 PI for SATs serotypes to account for an unpredicted high false positive response. These additional cut-offs were set as the mean of the single negative response of each serotype +5SD as estimated from the original validation data \[[@CR26]\]. According to the above defined thresholds, a strong positive response was thus considered at either a PI value of ≥70 or ≥80. Results from the SPCE were confirmed selecting a random sub-sample of the resulting SPCE positive reactive sera by Virus Neutralization Test (VNT), as prescribed by the World Organisation for Animal Health \[[@CR28]\], and using the O~1~ Manisa, A~22~ Iraq 24/64, C Phi 7/84, SAT 1 105, SAT 2 Eritrea, SAT 3 309 FMDV strains. Cut-off for positivity with the VNT was set at a titre of ≥1:45, whereas a titre of ≤1:11 and \>1:11 but ≤1:32 were considered as negative and inconclusive, respectively.

Data analysis {#Sec5}
-------------

The original database stored at the CIRAD and consisting of information collected through paper forms during the field campaigns was manipulated and inspected for missing and/or illogical data entries and completed and/or corrected whenever possible. The ELISA results were stored in an Access 2010 (Microsoft Corporation) database along with associated metadata, such as geographical location and GPS coordinates, national park and date of collection, species and age. Statistical analyses were performed in R 3.1.2 \[[@CR29]\], where confidence intervals were calculated using the Agresti-Coull estimation of binomial proportions \[[@CR30]\]. Univariate analysis was carried out by the Adjusted-Wald test, considering the effect of species, age, year of sampling, location and park area on FMD seroprevalence \[[@CR31]\]. All statistically significant variables (*p* \< 0.05 two-sided) in the univariate analysis were further assessed by a generalised linear model (GLM) with a *logit* function using a stepwise selection approach, in order to characterise potential risk factors associated with the observed FMD seroprevalence. The probability of FMD seroprevalence μ was then calculated by back-transforming the estimated *logit* values *g*(*x*) as $\documentclass[12pt]{minimal}
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                \begin{document}$$ \mu =\frac{e^{g(x)}}{1+{e}^{g(x)}} $$\end{document}$ \[[@CR32]\] and then introduced in a geospatial analysis environment using ArcGIS 10.2.2 (Environmental System Research Institute, Inc.) to produce a kernel smoothed intensity map of the predicted FMD prevalence \[[@CR33]\]. Pairwise correlation analysis based on the Pearson's product--moment coefficient (ρ) was undertaken on all possible combinations of PI estimates resulted from the SPCE testing \[[@CR34]\], where missing data were treated as pairwise deletions.

Results {#Sec6}
=======

The distributions of PI values resulted from the NS ELISA test for all the wildlife species (A) and for the buffalo samples only (B) are plotted in Figure [2](#Fig2){ref-type="fig"}. The 50th percentile for all species was reported as 34.2 PI (95%CI 32.0 -- 36.3), different from the buffalo distribution that returned a value of 62.0 PI (95%CI 55.1 -- 66.8). This figure would reflect a defined distinction between the seronegative (mainly non-buffalo species) and the seropositive (mainly buffalo) populations, confirmed by the bimodal distribution found for all species and the left-skewed distribution for the buffalo only. In addition, a total of 39 out of 89 (43.8%) positive samples for the non-buffalo species were found having a PI value of ≥70 in contrast with the 61.4% (78/127) estimated for the buffalo population. Thirteen out of 19 samples (68.4%) tested positive for cattle, confirming potential previous exposure of domestic livestock to the FMD; 84.6% (11/13) of those were returning PI values of ≥70.Figure 2**Histogram and kernel density plots of the NS ELISA percentage of inhibition values estimated for the complete dataset (A) and for buffalo only (B).** Red dash-dot line sets the cut-off point (PI = 50).

FMD seroprevalence in wildlife species: descriptive and univariate analyses {#Sec7}
---------------------------------------------------------------------------

The NSP testing of the non-buffalo wildlife reported FMD positivity in 89 out of 500 samples (17.8%, 95%CI 14.7% -- 21.4%), extracted from 16/27 species (59.3%). Among all the wildlife species assessed, presence of antibodies were found in individuals belonging to the *Alcelaphinae* (8.0%), *Antilopinae* (2.1%), *Bovinae* (14.3%), *Cephalophinae* (23.5%), *Hippotraginae* (7.1%), and *Reduncinae* (27.2%) sub-families (*Bovidae* family, 18.4%), and for species belonging to the *Suidae* family (11.6%). Bohor Reedbuck (*Redunca redunca*) (66.8%), Defassa Waterbuck (*Kobus ellipsiprymnus unctuosus*) (63.2%), Red-Flanked Duiker (*Cephalophus rufilatus*) (60.0%), Giant Eland (*Taurotragus derbianus*) (21.4%) and Topi (*Damaliscus korrigum jimela*) (21.4%) were the wild ruminants reporting high levels of FMD seropositivity (Table [2](#Tab2){ref-type="table"}). The only sample collected from hippopotami and tested positive to the NS ELISA (PI = 53) should be regarded as a false positive response to the NS ELISA test, recalling that previous studies conducted in the Kruger National Park failed to detect antibodies against the FMDV in this species \[[@CR2]\].Table 2Observed prevalence of FMDV NSP antibodies reported for all the wildlife species tested.**SpecieNo Positive/TOTObserved seroprevalence95% CI**African Bush Elephant (*Loxodonta Africana*)0/10%-African Forest Buffalo (*Syncerus caffer nanus*)0/40%-Blue Duiker (*Philantomba monticola*)1/520.0%2.0% - 64.0%Bohor Reedbuck (*Redunca redunca*)4/666.7%29.6% - 90.7%Bongo (*Tragelaphus eurycerus*)0/20%-Buffon's Kob (*Kobus kob*)24/17213.9%9.5% - 20.0%Bush Duiker (Sylvicapra grimmia)0/50%-Bushbuck (*Tragelaphus scriptus*)2/1513.3%2.5% - 39.1%Common Warthog (*Phacochoerus africanus*)4/2913.8%4.9% - 31.2%Defassa Waterbuck (*Kobus ellipsiprymnus unctuosus*)36/5763.2%50.1% - 74.5%Dorcas Gazelle (*Gazella dorcas*)0/400%-Giant Eland (*Taurotragus derbianus*)3/1421.4%6.8% - 48.3%Giant Forest Hog (*Hylochoeurs meinertzhageni*)0/10%-Greater Kudu (*Tragelaphus strepsiceros*)0/40%-Hartebeest (*Alcelaphus buselaphus*)1/205.0%0% - 25.4%Hippopotamus (*Hippopotamus amphibious*)1/1100%-Kordofan Giraffe (*Giraffa camelopardis antiquorum*)0/50%-Lelwel Hartebeest (*Alcelaphus buselaphus lelwel*)2/405.0%0.5% - 17.4%Nile Buffalo (*Syncerus caffer aequinoctialis*)115/16868.4%61.1% - 75.0%Nolan Warthog (*Phacochoerus africanus africanus*)0/70%-Oribi (*Ourebia ourebi*)1/714.3%0.5% - 53.3%Red River Hog (*Potamochoerus porcus*)1/616.7%1.1% - 58.2%Red-Flanked Duiker (*Cephalophus rufilatus*)3/560.0%22.9% - 88.4%Red-Fronted Gazelle (*Eudorcas rufifrons*)0/10%-Roan Antelope (*Hippotragus equinus*)2/287.1%0.9% - 23.7%Tiang (*Damaliscus korrigum korrigum*)1/520.0%2.0% - 64.0%Topi (*Damaliscus korrigum jimela*)3/1421.4%6.8% - 48.3%West African Buffalo (*Syncerus caffer brachyceros*)12/2450.0%31.4% - 68.6%Western Hartebeest (*Alcelaphus buselaphus major*)0/80%-Yellow-Backed Duiker (*Cephalophus silvicultur*)0/20%-**TOT Buffalo**127/19664.8%57.9% - 71.1%**TOT Other Wildlife**89/50017.8%14.7% - 21.4%**TOT Cattle**13/1968.4%45.8% - 84.8%Adjusted-Wald test F~(29,\ 667)~ = 10.06 (*p* = 0.000).

Effect of the region of collection was found to be of statistical significance on seroprevalence estimates (*p* = 0.003), where 19% of samples tested positive for Central Africa whilst presence of antibodies were detected in only few samples collected in West Africa (3/48). Filtering the results by country of origin, a high FMD prevalence was estimated in samples obtained from Chad (23.1%), although these data were obtained from mostly a single national park (Zakouma National Park), thus likely reflecting local conditions.

FMD seroprevalence in buffalo subspecies: descriptive and univariate analyses {#Sec8}
-----------------------------------------------------------------------------

In total, 127 out of 196 tested positive for FMD (64.8%, 95%CI 57.9% -- 71.1%). According to the subspecies of the *Syncerus* genus, a high level of NSP antibodies was reported in both Nile Buffalo (*Syncerus caffer aequinoctalis*) (68.4%) and West African Buffalo (*Syncerus caffer brachyceros*) (50.0%) (Table [3](#Tab3){ref-type="table"}). Although only few samples were tested (0/4), no FMDV reactive sera were found for African Forest Buffalo (*Syncerus caffer nanus*). The difference in seroprevalence observed between each of the buffalo sub-species was reported to be significant (*p* = 0.031).Table 3Observed prevalence of FMDV NSP antibodies reported for all the buffalo subspecies tested and filtered by age, year, country and park of collection.**No Positive/TOTObserved seroprevalence95% CIAge Group**Calf (≤6 m)1/1100%-Juvenile (\>6 m ≤2ys)3/560.0%22.9% - 88.4%Sub-adult (\>2ys ≤5ys)36/5170.6%56.9% - 81.4%Adult (\>5ys)78/12562.4%53.6% - 70.4%**Year**199930/4468.2%53.4% - 80.1%200029/5552.7%39.8% - 65.3%200113/2259.1%38.7% - 76.8%200249/6279.0%67.2% - 87.4%20036/1346.1%23.2% - 70.9%**Subspecie**Nile Buffalo115/16868.4%61.1% - 75.0%West African Buffalo12/2450.0%31.4% - 68.6%African Forest Buffalo0/40%-**Country**Benin8/1844.4%24.5% - 66.3%Burkina Faso4/580.0%36.0% - 98.0%Nigeria0/10%-**West Africa**12/2450.0%31.4% - 68.6%Central African Republic52/8164.2%53.3% - 73.8%Chad30/5356.6%43.3% - 69.1%Democratic Republic of Congo33/3497.1%83.8% - 100%Gabon0/40%-**Central Africa**115/17266.9%59.5% - 73.5%**Park**Pendjari National Park8/1844.4%24.5% - 66.3%Pama Reserve3/3100%-Arly National Park1/250.0%9.4% - 90.5%Borgu Game Park0/10%-Manovo-Gounda St. Floris National Park15/1978.9%56.1% - 92.0%Zemongo Faunal Reserve6/785.7%46.6% - 99.5%Bamingui-Bagoran National Park3/650.0%18.8% - 81.2%Zakouma National Park22/4153.7%38.7% - 67.9%Garamba National Park33/3497.1%83.8% - 100%Loango National Park0/40%-Adjusted-Wald test for age group F~(3,\ 178)~ = 0.72 (*p* = 0.542).Adjusted-Wald test for year F~(4,\ 192)~ = 3.03 (*p* = 0.019).Adjusted-Wald test for subspecie F~(2,\ 194)~ = 3.52 (*p* = 0.031).Adjusted-Wald test for country F~(6,\ 190)~ = 6.62 (*p* = 0.000).Adjusted-Wald test for region F~(1,\ 195)~ = 2.51 (*p* = 0.115).Adjusted-Wald test for park F~(9,\ 126)~ = 5.27 (*p* = 0.000).

The age mean of FMD seropositive individuals was estimated to be 9.1 ± 5.2 years with high FMD prevalence values described in those animals aged between 2 and 10 years. However, no effect (*p* = 0.542) of age on the FMD seropositivity levels extracted from each of the categories was observed (Table [3](#Tab3){ref-type="table"}), even though sub-adult and adult categories were those reporting high FMD prevalence and narrow interquartile range, which did not include PI values below the cut-off point. No significant difference between sexes was observed (*p* = 0.23).

Differences in seroprevalence estimates between sampling years were found to be statistically significant (*p* = 0.019). Overall, high level of FMD prevalence was reported in samples collected during 1999 (68.2%) and 2002 (79.0%), although observing a higher seroprevalence for West Africa in samples collected in 2000 (80.0%) as opposed to the seroprevalence (83.9%) reported for Central Africa in 2002.

No significant difference (*p* = 0.115) resulted for the regional prevalence distribution of FMD. Within each region, high FMD seroprevalence was found in Burkina Faso (80.0%) for West Africa, and in the Democratic Republic of Congo (97.1%) and Central Africa Republic (64.2%) for Central Africa (Table [3](#Tab3){ref-type="table"}).

Considering the area of origin, presence of high levels of antibodies against the NSPs was reported in those buffalo populations resident in the Garamba National Park (97.1%) of the Democratic Republic of Congo, the Zemongo Reserve (85.7%) and the Manovo-Gounda St. Floris National Park (78.9%) of the Central African Republic (Table [3](#Tab3){ref-type="table"}).

FMD spatial distribution in buffalo {#Sec9}
-----------------------------------

According to the GLM analysis (Table [4](#Tab4){ref-type="table"}), five main effect variables had statistically detectable association with the FMD positive status to the NS ELISA test observed for buffalo samples. Increased risk in the probability of FMD seropositivity was associated with the longitude (OR = 1.14, *p* = 0.011) of the sample locations, whereas a decrease in risk was reported according to the latitude (OR = 0.79, *p* = 0.000), year (OR = 0.72, *p* = 0.000) and park area (OR = 0.68, *p* = 0.009) variables entered in the model. The kernel smoothed intensity map produced using the predicted FMD prevalence is shown in Figure [5](#Fig5){ref-type="fig"}. The areas with high risk of FMD amongst the buffalo populations sampled, as predicted by the model, are located mainly in the bordering areas between south-west Chad and north-west Central African Republic, and in the north-east Democratic Republic of Congo that borders with South Sudan. This spatial range overlaps with the extent of the Aouk and Zakouma National Parks and the Aouk Aoukale Faunal Reserve in Chad, the Manovo-Gounda St. Floris and Bamingui-Bangoran National Parks in the Central African Republic. The Manouvo-Gounda St. Floris and the Zakouma National Parks constitute the same ecological area and, as evidenced by the model prediction and the prevalence reported, it is likely to be regarded as high risk of FMD.Table 4Generalised linear model (*logit* link) reporting the ORs with corresponding 95% CI for risk factors associated with the FMD seroprevalence reported for all the buffalo subspecies tested.**β \[95%CI\]SEZpOdds Ratio \[95%CI\]**Intercept4.11 \[1.57 -- 6.66\]1.233.160.002-Park (Km^2^)−0.38 \[−0.67 -- −0.97\]0.15−2.630.0090.68 \[0.51 -- 0.91\]Longitude0.13 \[0.03 -- 0.23\]0.052.530.0111.14 \[1.03 -- 1.26\]Latitude−0.23 \[−0.37 -- −0.10\]0.07−3.500.0000.79 \[0.69 -- 0.9\]Year−0.32 \[−0.48 -- −0.17\]0.08−4.100.0000.72 \[0.62 -- 0.84\]Age0.01 \[0 -- 0.01\]0.0024.310.0001.01 \[1 -- 1.01\]log-likelihood = −479.58; AIC = 973.17.Figure 3**Box plot of the SPCE percentage of inhibition values for buffalo samples according to each of the FMDV serotypes tested \[Overall (A) and regional (B) data\].** Cut-off was set at either a PI value of ≥50 or ≥60 for A, O and C serotypes, and at either a PI value of ≥40 or ≥50 for SATs serotypes (red dotted lines) outlier.

FMDV serotyping profile in buffalo: descriptive and correlation analyses {#Sec10}
------------------------------------------------------------------------

The overall results from the SPCE analysis of buffalo samples showed presence of antibodies against all the 6 FMDV serotypes tested (Figure [3](#Fig3){ref-type="fig"}), with high levels estimated for O (82.3%), SAT 2 (81.9%) and SAT 1 (73.2%) serotypes (Table [5](#Tab5){ref-type="table"}). Increasing the cut-off as described in the methodology section did not largely change the seroprevalence patterns found for O, SAT 1 and SAT 2 FMDV serotypes, differently from the A, C and SAT 3 seropositivities which were reduced to the order of 50%. In addition, 41 out of 102 positive samples (40.2%), 44/104 (42.3%) and 19/93 (20.4%) returned PI values ≥80 for type O, SAT 2 and SAT 1, respectively.Figure 4**Scatterplot matrix of the pairwise correlation analysis estimated between PI values obtained from buffalo samples tested for each of the FMDV serotypes by SPCE.** Variables are reordered and coloured according to the returned Pearson correlation values \[blue (ρ ≤ 0.3); yellow (0.3 \>ρ ≤ 0.5); red (ρ ≥ 0.5)\], where higher correlated variables are plot near the diagonal.Table 5Observed prevalence of serotype-specific FMDV antibodies reported for all the buffalo subspecies tested as overall result and by region of collection.**SerotypeNo Positive/TOTObserved seroprevalence** ^**†**^**95%CIWest Africa**A6/1250.0%25.4% - 74.6%O6/1250.0%25.4% - 74.6%C7/1258.3%31.9% - 80.7%SAT 18/1266.7%38.8% - 86.4%SAT 29/1275.0%46.1% - 91.7%SAT 33/1225.0%8.3% - 53.8%**Central Africa**A50/11543.4%34.8% - 52.6%O96/11285.7%77.9% - 91.1%C77/11567.0%57.9% - 74.9%SAT 185/11573.9%65.2% - 81.1%SAT 295/11582.6%74.6% - 88.5%SAT 356/11548.7%39.7% - 57.7%**TOT**A56/12744.1%35.8% - 52.8%O102/12482.3%74.5% - 88.0%C84/12766.1%57.5% - 73.8%SAT 193/12773.2%64.9% - 80.2%SAT 2104/12781.9%74.2% - 87.7%SAT 359/12746.5%38.0% - 55.1%^†^Cut-off values set as ≥50 for A, O and C serotypes, and ≥40 for SATs serotypes.

Interestingly, the pattern of FMD prevalence for each of the 6 serotypes tested was shaped differently according to the region of collection. Although high level of antibody responses against both SAT 1 and SAT 2 FMDV serotypes were recorded for both West and Central Africa, higher prevalence of type O, C and SAT 3 were found in samples collected from Central African countries. Moreover, considering the distribution of PI values returned for each of the 6 serotypes by region (Figure [3](#Fig3){ref-type="fig"}), the third quartile (*Q*~3~) of type A, O, SAT 3 and to some extent of C results obtained for the West Africa samples was set below the threshold values and the data distributions of type A and O were largely right-skewed (with most of the data lying below the cut-off points), in contrast with what reported for Central Africa.

Different patterns of reaction to the 6 FMDV serotypes tested were recorded, from sera only positive for a single serotype to multiple reactivities. A number of sera with the highest serotype-specific responses (i.e. highest PI values) were identified for type O (16.7%, 2/12), C (16.7%, 2/12) and SAT 2 (58.3%, 7/12) in samples collected from West Africa, and for type A (2.6%, 3/115), O (47.8%, 55/115), C (5.2%, 6/115), SAT 1 (14.8%, 17/115), SAT 2 (27.0%, 31/115) in those retrieved from Central Africa (Table [6](#Tab6){ref-type="table"}). No sera with the highest serotype-specific response for SAT 3 were reported, even though PI values of up to 79 and 87 were estimated from samples of West and Central Africa, respectively. The potential cross-reaction between pairs of serotypes tested was then assessed computing the pairwise correlation matrix of continuous data (PI values) for all the samples analysed (Figure [4](#Fig4){ref-type="fig"}). Statistically significant correlations (*p* = 0.000) with high ρ coefficients were reported for the A--SAT 1 (0.66), A--SAT 3 (0.61), SAT 1--SAT 3 (0.70), C--SAT 3 (0.67) and C--SAT 2 (0.54) pairs. No correlation was found between O and any of the other FMDV serotypes tested (ρ≤ 0.1; *p* \> 0.05). The random sample (*n* = 43) extracted from the SPCE positive data was confirmed by the VNT test, which reported positive results at the highest titre of 1:90, 1:178, 1:256, 1:1024 and 1:355 for O, C, SAT 1, SAT 2 and SAT 3 FMDV serotypes, respectively. Inconclusive results were obtained for type A (titre of 1:22).Table 6Number of buffalo sera with highest serotype-specific FMDV antibodies response \[highest PI value\] per serotype tested positive on the SPCE by country of collection.**AOCSAT 1SAT 2SAT 3**Benin0/8 \[[@CR60]\]2/8 \[73\]2/8 \[92\]0/8 \[87\]3/8 \[92\]0/8 \[79\]Burkina Faso0/4 \[[@CR63]\]0/4 \[[@CR67]\]0/4 \[71\]0/4 \[76\]4/4 \[99\]0/4 \[[@CR40]\]**West Africa**0/12 \[[@CR63]\]2/12 \[73\]2/12 \[92\]0/12 \[87\]7/12 \[99\]0/12 \[79\]Central African Republic1/52 \[80\]22/52 \[95\]4/52 \[85\]11/52 \[98\]13/52 \[93\]0/52 \[87\]Chad2/30 \[75\]9/30 \[85\]2/30 \[74\]2/30 \[87\]13/30 \[96\]0/30 \[81\]Democratic Republic of Congo0/33 \[82\]24/33 \[108\]0/33 \[88\]4/33 \[97\]5/33 \[90\]0/33 \[83\]**Central Africa**3/115 \[82\]55/115 \[108\]6/115 \[88\]17/115 \[98\]31/115 \[96\]0/115 \[87\]Figure 5**Kernel density map of the predicted probability μ of FMD seropositivity in buffalo as estimated from the generalised linear model (** ***logit*** **link).** Geographical extent of African wildlife protected areas are sourced and adapted from \[[@CR69]\].

Discussion {#Sec11}
==========

This study reports the FMD serological profile extracted from wildlife populations inhabiting the rangelands of West and Central Africa. The results confirm that FMDV circulates within wildlife-livestock ecosystems present in the study regions and in particular in buffalo subspecies, also suggesting that multiple FMDV serotypes may be involved with type O, SAT 2 and SAT 1 being dominant. A different pattern of FMD prevalence for each of the serotypes tested was reported between West and Central Africa, with high levels of serotype-specific antibodies against type O, C and SAT 3 found in buffalo samples sourced from Central Africa. These results would indicate a distinct geographical extent of FMDV serotypes circulating in buffalo populations present in West and Central Africa, which might be associated with transboundary movements of FMDV lineages and, thus, in line with what has been historically described for the FMDV pools 4 and 5 \[[@CR35],[@CR36]\]. Although historical data of FMDV isolates recovered from buffalo samples within the countries under study at the time of the sampling were generally not available, the here defined FMD distribution in wild ruminants of West and Central Africa might largely contribute in providing a clearer picture of the FMD burden in those largely unstudied regions of sub-Saharan Africa. The reported outbreaks affecting livestock of West Africa since 2000 were caused by FMDV types A, O and SAT 2 circulating in Benin (O and A in 2010), Burkina Faso (O in 2002), Cameroon (O in 2000 and 2005; A and SAT 2 in 2000, 2005 and 2012--13), Mali (O in 2004--05; A in 2004 and 2006), Mauritania (O in 2000--01; A in 2006), Niger (O in 2001 and 2005; SAT 2 in 2007--08 and 2011--12), Senegal (O in 2001 and 2006; SAT 2 in 2009), Togo (O in 2004--05; A in 2005) \[[@CR37]-[@CR43]\]. From 1970, reports of FMD activities in Central Africa were only available for types A and SAT 2 in Chad (1973 and 1972, respectively) and for the Democratic Republic of Congo (O in 2006 and 2010; A in 2011; SAT 2 in 1974, 1979 and 1982) \[[@CR44]\]. FMDV type C has never been reported in West and Central Africa and, moreover, up until 2004 this FMDV serotype was only confined to East Africa in Kenya (1957--2004), Ethiopia (1957--1983) and Uganda (1970--71), from when it seems to have been extinct \[[@CR45]\]. A very striking results provided from this study is the relatively high proportion (84/127) of serotype C positive sera, although with only 6 producing very high PI values. This may either indicate a potential cross-reactivity with other serotypes (high correlations were found between C and both SAT 2 and SAT 3) or that serotype C may have been circulating without being detected, with the latter less plausible. The SAT 3 serotype has been mainly documented in Southern African countries with occasional isolations in Uganda (1970 and 1997) from samples collected from Cape Buffalo in the southern part of the Queen Elizabeth National Park \[[@CR46],[@CR47]\]. In 2013, FMDV SAT 3 was isolated from a sub-clinically (or persistently) infected Ankole calf at Nyakatonzi (Kasese District), in close proximity to the northern part of the Queen Elizabeth National Park \[[@CR48]\]. These finding may indicate that this serotype is also potentially maintained in buffalo populations present in wildlife ecosystems of Eastern Africa \[[@CR17]\].

The SPCE test used in this study for the qualitative and quantitative detection of antibodies against the FMDV serotypes has previously proven to be more robust and specific, and equally sensitive to the Liquid Phase Blocking ELISA (LPBE) \[[@CR26]\], but not totally unaffected by serological cross-reactivity between FMDV serotypes, thus representing a valid, easy and fast to process alternative to the VNT. It should be noted that the SPCE has not been validated for testing wildlife sera, but only for cattle, pigs and sheep \[[@CR26],[@CR27]\], and this might have an impact on the results here generated. However, the selection of higher cut-off values for the SPCE positivity threshold, aiming at reducing a potential false positive response, did not change the seroprevalence figures here reported and, furthermore, several buffalo samples returned PI values of ≥80 thus indicating presence of high antibody levels. In addition, a random sample of the positive sera generated from the SPCE has been confirmed by VNT testing. The mismatch between the strains used for the VNT testing and antibodies present in the sera might have an impact on the results obtained. However, the precise selection of an appropriate test antigen would not be possible when testing sera of unknown status and, therefore, it has been assumed that antigenic differences were limited, with positive samples still producing high titres to the specific strains than to the other serotypes. Although correlations between serotype-specific responses have been evaluated, the extent to which findings of individual sera reactive to multiple serotypes is due to serological cross-reactivity or multiple infections has not been entirely ruled out. However, subsequent multiple serotypes infections do occur and even simultaneous multiple infection cannot be excluded. In a previous study it has been demonstrated that buffalo carriers are refractory to reinfection with the same strain of virus \[[@CR49],[@CR50]\] thus supporting the hypothesis of potential co-infections and/or subsequent infections with more than one serotypes. Although the results here reported suggest infections of buffalo subspecies with different FMDV serotypes, there is little published on non-SAT serotypes in buffalo population \[[@CR19]-[@CR23]\], with no evidences supporting the hypothesis that domestic types of FMDV has come from buffalo as carrier. In a recent study, the phylogenetic descent of the SAT 2 serotype across the entire African continent was regarded to have originated from a FMDV ancestor formerly infecting Cape buffalo, also evaluating that interspecies virus transitions might occur between Cape buffalo and cattle, and vice versa \[[@CR51]\]. Although this would support the hypothesis of FMDV shifting between wildlife and livestock, the incomplete and biased nature of the analysed data could potentially derive confounding results. Nevertheless, genetic and epidemiological analyses have clearly shown on specific occasions the close relationship between SATs viruses infecting buffalo and other wild species (e.g. Impala) to those causing outbreaks in cattle \[[@CR16],[@CR52],[@CR53]\]. In addition, a field study conducted in Ethiopia found significant association between cattle exposed to FMDV and their contact history with wildlife \[[@CR54]\], whilst a recent study conducted at the periphery of protected areas in Zimbabwe indicates that interactions between livestock and buffalo populations can account for FMD primary outbreaks \[[@CR55]\]. Besides studies based on serological investigations, to what extent types of FMDV prevalent in domestic ruminants infect wildlife is unknown; hence, until this issue is investigated thoroughly it will constitute a major deficiency in understanding the epidemiology of FMD in large parts of sub-Saharan Africa. Therefore, further field studies are warranted to collect clinical samples, in order to enable the genome characterisation of FMDV lineages circulating within wild animal species of West and Central Africa and to confirm if FMDV serotypes normally present in domestic livestock are really mixing with buffalo and, thus, eventually become established in those populations. However, it should be noticed that two significant buffalo populations at present exist in West and Central Africa, which are susceptible to share cattle grounds (Figures [1](#Fig1){ref-type="fig"} and [5](#Fig5){ref-type="fig"}): the W-Arly-Pendjari (WAP) Parks Complex (tranfrontier area shared between Benin, Burkina Faso and Niger, which hosts around 10000+ buffalo) and the Zakouma National Park (which hosts around 7000+ buffalo). This geographic distribution of buffalo would therefore likely contribute to reduce the mixing between buffalo and livestock thus decreasing the risk of FMD transmission.

Wild animal species already reported to be susceptible to the FMDV \[[@CR7]\] were confirmed in this study. In addition, presence of antibodies against the FMDV has not been previously described in Buffon's Kob (*Kobus kob*) and Oribi (*Ourebia ourebi*), therefore increasing the number of wild ruminant species reported to be susceptible to FMD infection in sub-Saharan Africa. In addition, the FMD prevalence found in non-buffalo species of West and Central Africa is higher than what has previously been reported in other studies targeting wildlife ecosystems of Eastern Africa and Zimbabwe \[[@CR17],[@CR18],[@CR56]\]. The high FMD prevalence found in Bohor Reedbuck and Waterbuck might reflect their ecology and living ecosystem: in fact they are dependent on water with living habitats close to water sources, which might indicate a link between FMD transmission within and between wildlife species (and/or between domestic and wild animals) when congregating at watering points. This study provides the first evidence of FMDV exposure in subspecies of the *Syncerus* genus other than the Cape buffalo \[[@CR7]\], thus accounting for their potential role in the epidemiology of FMD outside the living habitat of Cape buffalo in Eastern and Southern African regions. Although the predicted spatial distribution of FMD in buffalo might reflect the epidemiological status at the time of the sampling, a generalisation to the current situation might be expected since no effective control measures have been implemented in recent years either in West or Central African regions, and up-to-date data have not been published. In addition, although accounting for the extent of the protected areas present in West and Central Africa, the predicted FMD spatial distribution was not intended to resolve the landscape structure of the study regions, and so this might cover areas where buffalo ecological niches might be absent. Therefore, a more extensive sampling frame would be required to provide a more exhaustive indication of the spatial burden of FMD in wildlife ecosystems of West and Central Africa. This initial attempt would, nevertheless, provide useful information to be linked for a broad scale strategic FMD monitoring planning.

According to the buffalo subspecies tested, the FMD prevalence found might reflect the different social organization and population biology of each of the subspecies considered. For example, the African forest buffalo herds are quite isolated, have a small animal density (herd size of about 3--25 individuals) and move in a limited home-range (\~2.3--8 km^2^) compared to the Cape buffalo. In addition, they have a very secretive behaviour and a limited distribution, mainly found in rainforest ecosystem \[[@CR57]\]. Savannah buffalo (West African and Nile buffalo) more frequently split into smaller herds, herd-switching is more common and they have a large home range. This is opposed to Cape buffalo herds that are more densely populated (e.g. mass herds can vary from few hundreds up to several thousand individuals) and engage in long-distance dispersal \[[@CR58]\]. In a previous study conducted in Cape buffalo population of East Africa, a 67.7% of the total samples tested was reported as FMD positive \[[@CR17]\]. Therefore, this might indicate different patterns of FMD susceptibility across the different buffalo subspecies that might be linked to the species ecology, even though only four African forest buffalo samples were available for testing. In fact, susceptibilities to the FMDV of buffalo living in savannah habitat are consistent across sub-species but African forest buffalo might show a different epidemiology. On the other hand, this could be a concurrent result of the host living habitat, the social behaviour of each of the buffalo subspecies, and the extent of the FMD geographical distribution (i.e. the African forest buffalo samples were collected from Gabon, in which FMD has never been reported in the periods between 1996 and 2003 \[[@CR59]\], and between 2006 and 2012 \[[@CR60]\]). In addition, it should be noted that the African forest buffalo were darted in the Loango National Park where the livestock presence is very low and especially absent from the darting area, that means lack of contacts between buffalo and cattle besides the very low size of herds (\<8 heads). From the model estimates, the odds of a buffalo resulting FMD positive by NS ELISA is reduced by 0.98 for every 10 km^2^ increase in the park area. This would be directly correlated with the density of buffalo population, which might indicate that in large ecosystems herds tend to be sparser, not overlapping their home ranges, and thus diminishing the risk of transmitting and maintaining the disease. In addition, the rainforest area of western and central Africa represents a limiting factor for the spatial and demographic expansion of buffalo herds (and livestock), as would be the case for African forest buffalo that mainly inhabits forest clearings \[[@CR61]\]. Figures indicate that 89.3% of rainforests is present in Central Africa, where the Democratic Republic of Congo accounts for the largest African lowland rainforest area (53.6%) \[[@CR62]\]. However, the FMD prevalence (97.1%) obtained from the Democratic Republic of Congo was resulting from Nile buffalo samples collected in the Garamba National Park, which mainly covers vast grass savannahs and woodlands. Furthermore, density of buffalo population fluctuates according to seasons, which tend to be reduced during the dry season as at this time of the year the size of the area for grazing and watering is really reduced compared to the rainy season.

Direct contacts between buffalo and livestock seem to be rare, with degrees of variability determined by ecosystem structure and climatic cycles. It seems to be more common in open habitats and with plains species (e.g. during mass migration of wildebeest, topi, zebra and gazelles as in the Mara-Serengeti ecosystem in East Africa) and during the dry seasons, when water availability constrains animals to closely congregate thus increasing the transmission likelihood of water-related infections \[[@CR63]\]; in fact, these are also the times of the highest level of residency and density within protected areas of both livestock and buffalo. In addition, it should be noted that wildlife usually avoids livestock and human contacts (i.e. at watering points or locations with key forage resources) in a space-time fashion unless habituated. As FMD requires a relatively close contact setting for interspecies transmission, the FMD interface between wildlife and livestock should, therefore, not be seen as a direct physical interaction but as an indirect contact (i.e. through soil, forage and water contaminated by bodily discharge of infected animals), which might be regarded as the most likely factor to be associated with the risk of FMDV transfer from domestic to wildlife species. Eventually, the spread of FMD within the wildlife-domestic interface might be driven by a complex interplay of risk factors, including biophysical and climatic features, ecological traits and human practices.

The control of the wildlife-livestock interface in the transmission of FMD has been only successfully applied in South Africa at a considerable ecological and economic cost \[[@CR64],[@CR65]\] by the means of herds separation (e.g. strict land-use policies, animal movement controls and fencing) and buffer vaccination of livestock population around the source of virus \[[@CR66]\]. However, in countries where wildlife populations are integrated with extensive nomadic and semi-nomadic pastoralism, as would be the case for West and Central Africa, the risk of FMD spread increases not only for the difficulty in applying effective control measures (e.g. pastoralists usually rely on ethnoveterinary practices \[[@CR67]\] and move within and between countries in an uncontrolled fashion), but also for the increase in the land-use pressure and conflict between pastoralists and wildlife competing for grazing and water resources. As example, the St. Floris National Park, Central African Republic, is boasting a large population of buffalo and is a grazing and transhumance crossing land for the Fulani pastoralist tribe. A 78.9% of FMD prevalence in Nile buffalo has been reported in this ecosystem, with high serotype-positive responses against type O, SAT 1 and SAT 2. The demographic growth, the expansion of cultivation (e.g. agro-pastoral systems), the development of local governance on natural resources \[[@CR65]\] and the reduction of rangeland resources in Africa have indeed led to increased sharing of resources between domestic and wildlife species and hence the risk of diseases transmission. However, the ecological processes driving the FMDV evolution and transmission in the sub-Saharan African ecosystems still remain poorly documented. In this context the nature of the wildlife-livestock interface in pastoral landscapes and its complex socio-ecological-economic interactions have not been entirely studied and need to be thoroughly investigated. The importance and, at the same time, the difficulties in controlling the FMD in the sub-Saharan Africa relies on the unique diversity and numbers of the wild species present and the explosive growth of the human population, which consequently needs to create solutions that would work for improving the agriculture standards, the sanitary safety of livestock trade, the sustainable land use and the biodiversity conservation of wildlife ecosystems.
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